Lrrc14 - leucine rich repeat containing 14

Predicted to enable kinase binding activity. Predicted to be involved in negative regulation of NF-kappaB transcription factor activity and negative regulation of toll-like receptor signaling pathway. Predicted to be active in cytoplasm. Is expressed in several structures, including branchial arch; genitourinary system; inner ear; lung; and nervous system. Orthologous to human LRRC14 (leucine rich repeat containing 14). [provided by Alliance of Genome Resources, Apr 2022]